Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD

Primary hyperoxaluria type 2

Nedosiran in Pediatric Patients From Birth to 5 Years of Age With PH and Relatively Intact Renal Function Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD Rare Kidney Stone Consortium Biobank International Registry for Primary Hyperoxaluria Long Term Extension Study in Patients With Primary Hyperoxaluria A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2